These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 34692494)

  • 41. Magnetic resonance imaging profile of blood-brain barrier injury in patients with acute intracerebral hemorrhage.
    Aksoy D; Bammer R; Mlynash M; Venkatasubramanian C; Eyngorn I; Snider RW; Gupta SN; Narayana R; Fischbein N; Wijman CA
    J Am Heart Assoc; 2013 May; 2(3):e000161. PubMed ID: 23709564
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of Bevacizumab Treatment in Cerebral Radiation Necrosis : Investigation of Response Predictors in a Single-Center Experience.
    Lee SH; Choi JW; Kong DS; Seol HJ; Nam DH; Lee JI
    J Korean Neurosurg Soc; 2023 Sep; 66(5):562-572. PubMed ID: 36642947
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Antiangiogenic therapy for primary liver cancer: correlation of changes in dynamic contrast-enhanced magnetic resonance imaging with tissue hypoxia markers and clinical response.
    Yopp AC; Schwartz LH; Kemeny N; Gultekin DH; Gönen M; Bamboat Z; Shia J; Haviland D; D'Angelica MI; Fong Y; DeMatteo RP; Allen PJ; Jarnagin WR
    Ann Surg Oncol; 2011 Aug; 18(8):2192-9. PubMed ID: 21286939
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Evaluating the Relationship Between Dynamic Contrast-Enhanced MRI (DCE-MRI) Parameters and Pathological Characteristics in Breast Cancer.
    Kang SR; Kim HW; Kim HS
    J Magn Reson Imaging; 2020 Nov; 52(5):1360-1373. PubMed ID: 32524658
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Influence of Bevacizumab on Blood-Brain Barrier Permeability and
    Stegmayr C; Oliveira D; Niemietz N; Willuweit A; Lohmann P; Galldiks N; Shah NJ; Ermert J; Langen KJ
    J Nucl Med; 2017 May; 58(5):700-705. PubMed ID: 28153956
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Distinguishing recurrent high-grade gliomas from radiation injury: a pilot study using dynamic contrast-enhanced MR imaging.
    Bisdas S; Naegele T; Ritz R; Dimostheni A; Pfannenberg C; Reimold M; Koh TS; Ernemann U
    Acad Radiol; 2011 May; 18(5):575-83. PubMed ID: 21419671
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Tracer kinetic modelling for DCE-MRI quantification of subtle blood-brain barrier permeability.
    Heye AK; Thrippleton MJ; Armitage PA; Valdés Hernández MDC; Makin SD; Glatz A; Sakka E; Wardlaw JM
    Neuroimage; 2016 Jan; 125():446-455. PubMed ID: 26477653
    [TBL] [Abstract][Full Text] [Related]  

  • 48. 7T dynamic contrast-enhanced MRI for the detection of subtle blood-brain barrier leakage.
    Canjels LPW; Jansen JFA; van den Kerkhof M; Alers RJ; Poser BA; Wiggins CJ; Schiffer VMMM; van de Ven V; Rouhl RPW; Palm WM; van Oostenbrugge RJ; Aldenkamp AP; Ghossein-Doha C; Spaanderman MEA; Backes WH
    J Neuroimaging; 2021 Sep; 31(5):902-911. PubMed ID: 34161640
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Bevacizumab vs laser interstitial thermal therapy in cerebral radiation necrosis from brain metastases: a systematic review and meta-analysis.
    Palmisciano P; Haider AS; Nwagwu CD; Wahood W; Aoun SG; Abdullah KG; El Ahmadieh TY
    J Neurooncol; 2021 Aug; 154(1):13-23. PubMed ID: 34218396
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Value of DCE-MRI and FDG-PET/CT in the prediction of response to preoperative chemotherapy with bevacizumab for colorectal liver metastases.
    De Bruyne S; Van Damme N; Smeets P; Ferdinande L; Ceelen W; Mertens J; Van de Wiele C; Troisi R; Libbrecht L; Laurent S; Geboes K; Peeters M
    Br J Cancer; 2012 Jun; 106(12):1926-33. PubMed ID: 22596235
    [TBL] [Abstract][Full Text] [Related]  

  • 51. DCE and DSC perfusion MRI diagnostic accuracy in the follow-up of primary and metastatic intra-axial brain tumors treated by radiosurgery with cyberknife.
    Morabito R; Alafaci C; Pergolizzi S; Pontoriero A; Iati' G; Bonanno L; Gaeta M; Salpietro FM; Mormina E; Longo M; Granata F
    Radiat Oncol; 2019 Apr; 14(1):65. PubMed ID: 30992043
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Dynamic contrast-enhanced MRI of nasopharyngeal carcinoma: correlation of quantitative dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) parameters with hypoxia-inducible factor 1α expression and tumor grade/stage.
    Liu L; Hu L; Zeng Q; Peng D; Chen Z; Huang C; Liu Z; Wen Q; Zou F; Yan L
    Ann Palliat Med; 2021 Feb; 10(2):2238-2253. PubMed ID: 33725777
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Dynamic contrast-enhanced MRI shows altered blood-brain barrier function of deep gray matter structures in neuroborreliosis: a case-control study.
    Lindland ES; Solheim AM; Andreassen S; Bugge R; Eikeland R; Reiso H; Lorentzen ÅR; Harbo HF; Beyer MK; Bjørnerud A
    Eur Radiol Exp; 2023 Sep; 7(1):52. PubMed ID: 37710058
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Dynamic Contrast-enhanced Magnetic Resonance Imaging Permeability Parameters Monitor the Early Response to Bevacizumab Plus Chemotherapy in Colorectal Cancer Patients with Liver Metastases].
    Liu D; Qian HF
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2018 Apr; 40(2):256-263. PubMed ID: 29724317
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Laser interstitial thermal therapy (LITT) vs. bevacizumab for radiation necrosis in previously irradiated brain metastases.
    Sujijantarat N; Hong CS; Owusu KA; Elsamadicy AA; Antonios JP; Koo AB; Baehring JM; Chiang VL
    J Neurooncol; 2020 Jul; 148(3):641-649. PubMed ID: 32602021
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Dynamic contrast enhanced-MRI for the detection of pathological complete response to neoadjuvant chemotherapy for locally advanced rectal cancer.
    Gollub MJ; Gultekin DH; Akin O; Do RK; Fuqua JL; Gonen M; Kuk D; Weiser M; Saltz L; Schrag D; Goodman K; Paty P; Guillem J; Nash GM; Temple L; Shia J; Schwartz LH
    Eur Radiol; 2012 Apr; 22(4):821-31. PubMed ID: 22101743
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Dynamic contrast-enhanced magnetic resonance imaging may act as a biomarker for vascular damage in normal appearing brain tissue after radiotherapy in patients with glioblastoma.
    Fahlström M; Fransson S; Blomquist E; Nyholm T; Larsson EM
    Acta Radiol Open; 2018 Nov; 7(11):2058460118808811. PubMed ID: 30542625
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Blood-brain barrier dysfunction following traumatic brain injury: correlation of K(trans) (DCE-MRI) and SUVR (99mTc-DTPA SPECT) but not serum S100B.
    Winter C; Bell C; Whyte T; Cardinal J; Macfarlane D; Rose S
    Neurol Res; 2015 Jul; 37(7):599-606. PubMed ID: 25749458
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Dynamic contrast-enhanced and dynamic susceptibility contrast perfusion MR imaging for glioma grading: Preliminary comparison of vessel compartment and permeability parameters using hotspot and histogram analysis.
    Santarosa C; Castellano A; Conte GM; Cadioli M; Iadanza A; Terreni MR; Franzin A; Bello L; Caulo M; Falini A; Anzalone N
    Eur J Radiol; 2016 Jun; 85(6):1147-56. PubMed ID: 27161065
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The quantification of blood-brain barrier disruption using dynamic contrast-enhanced magnetic resonance imaging in aging rhesus monkeys with spontaneous type 2 diabetes mellitus.
    Xu Z; Zeng W; Sun J; Chen W; Zhang R; Yang Z; Yao Z; Wang L; Song L; Chen Y; Zhang Y; Wang C; Gong L; Wu B; Wang T; Zheng J; Gao F
    Neuroimage; 2017 Sep; 158():480-487. PubMed ID: 27402601
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.